Metastatic Breast Cancer in Austria

NCT03870620 · tracked via the Priya Life Science Austria tracker

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase

Observational

Started

2015-06-15

Last updated

2025-04-10

Condition(s) studied

Breast CancerBreast CarcinomaBreast Tumor

Study summary

Breast cancer is the most common cancer among women worldwide. In Austria, this diagnosis is made more than 5000 times a year (STATISTICS AUSTRIA, Austrian Cancer Registry, as of 24.09.2012). Of these, already 5% to 10% have distant metastases at the time of initial diagnosis, and up to 30% of the node-negative tumours and up to 70% of the node-positive tumours metastasise at a later date. Metastatic breast cancer has not been systematically assessed in Austria to date. This medical registry of the AGMT is thus the first Austrian-wide standardised documentation of this disease. The aim of the registry is to answer both epidemiological and therapy-specific questions.

This registry is a prospective and retrospective, multicentre collection of data on patients with metastatic breast cancer in Austria. All tumour characteristics, medical histories and also treatment sequences are documented in anonymised form.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Histological evidence of breast cancer * Histological and/or radiological evidence of metastases * Metastasis within 10 years of registry initiation * Signed informed consent (if a patient has already died at the time of entry, the entry can be made without a declaration of consent) Exclusion Criteria: * Due to the non-interventional design of the registry there are no specific exclusion criteria.

Primary outcome measure(s)

Number of patients with prognostic factors for metastatic breast cancer — 10 years
Number of patients according to molecular subtypes — 10 years
Frequency and tumour characteristics of breast cancer in male patients — 10 years
Overall survival of patients with metastatic breast cancer in Austria — 10 years

Trial sites (16)

Facility	City	Region	Status
Landeskrankenhaus Salzburg Universitätsklinikum der Paracelsus Medizinischen Privatuniversität; Universitätsklinik für Innere Medizin III Salzburg	Salzburg	State of Salzburg	Recruiting
AKH Wien; Universitätsklinik für Frauenheilkunde: Klin. Abt. f. Allg. Gynäkologie und gynäkologische Onkologie	Vienna	State of Vienna	Recruiting
Steiermärkische Krankenanstalten- gesellschaft m. b. H. LKH-Univ. Klinikum Graz; Universitätsklinik für Innere Medizin; Klinische Abteilung für Onkologie	Graz	Styria	Recruiting
Landeskrankenhaus - Universitätskliniken Innsbruck; Universitätsklinik für Frauenheilkunde Innsbruck	Innsbruck	Tyrol	Recruiting
BKH Kufstein; Innere Medizin: Interne II und onk. Tagesklinik	Kufstein	Tyrol	Recruiting
Kepler Universitätsklinikum; Univ.-Klinik für Hämatologie und Internistische Onkologie	Linz	Upper Austria	Recruiting
Ordensklinikum Linz GmbH - Barmherzige Schwestern; Interne I: Medizinische Onkologie und Hämatologie	Linz	Upper Austria	Recruiting
Pyhrn-Eisenwurzen Klinikum Steyr; Innere Medizin II: Onkologie, Gastroenterologie, Angiologie	Steyr	Upper Austria	Recruiting
Klinikum Wels-Grieskirchen GmbH; Abteilung für Innere Medizin IV	Wels	Upper Austria	Recruiting
LKH Feldkirch; Innere Medizin II/ Interne E (Hämatologie und Onkologie)	Feldkirch	Vorarlberg	Recruiting
Krankenhaus St. Josef Braunau; Inneren Medizin 2	Braunau am Inn	Austria	Recruiting
Krankenhaus der Stadt Dornbirn; Brustgesundheitszentrum Dornbirn	Dornbirn	Austria	Recruiting
Steiermärkische Krankenanstalten- gesellschaft m.b.H. LKH Hochsteiermark; Department für Hämato-Onkologie	Leoben	Austria	Recruiting
Universitätsklinikum St. Pölten; Abteilung für Innere Medizin 1	Sankt Pölten	Austria	Recruiting
UK AKH Wien: Universitätsklinik für Innere Medizin I: Klinische Abteilung für Onkologie	Vienna	Austria	Recruiting
Klinik Ottakring; 1. Med. Abteilung, Zentrum f. Onkologie, Hämatologie und Palliativmedizin	Vienna	Austria	Recruiting

More Arbeitsgemeinschaft medikamentoese Tumortherapie trials in Austria

AGMT Austrian Lymphoma Registry Recruiting

AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry Recruiting

Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM Active, not recruiting

Lung Cancer Registry Recruiting

Austrian Myeloid Registry Recruiting

Other trials for the same condition

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST Active, not recruiting

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer Active, not recruiting

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients Active, not recruiting

A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer. Active, not recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03870620 on ClinicalTrials.gov ↗ ← All trials in Austria